Valuation Repligen Corporation

Stocks

Market Closed - Nasdaq 01:00:00 13/11/2026 +04			5-day change	1st Jan Change
166.52 ^USD	-3.53%		-1.16%	+1.62%

11-02	Repligen 'Very Confident' in Filtration Business Returning to Historical Growth Rates Next Year, RBC Says	MT
10-30	Repligen Corporation announced that it expects to receive $458.6 million in funding	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	14,643	9,401	10,039	8,064	9,224	10,645	-	-
Change	-	-35.8%	6.78%	-19.67%	14.38%	15.4%	-	-
Enterprise Value (EV) ¹	14,405	9,062	9,357	7,833	9,200	9,834	9,623	9,352
Change	-	-37.09%	3.26%	-16.29%	17.46%	6.89%	-2.14%	-2.82%
P/E	118x	52.3x	243x	-313x	191x	-557x	115x	72x
PBR	8.67x	4.92x	5.09x	4.09x	4.38x	3.28x	3.33x	3.11x
PEG	-	1.2x	-3.1x	2x	-1x	4x	-0x	1.2x
Capitalization / Revenue	21.8x	11.7x	15.7x	12.7x	12.5x	12.5x	9.95x	8.57x
EV / Revenue	21.5x	11.3x	14.6x	12.3x	12.5x	11.6x	9x	7.53x
EV / EBITDA	62.5x	36.7x	73.1x	66.8x	65.6x	55.5x	38.9x	29.2x
EV / EBIT	66.9x	39x	99.2x	95.4x	90.4x	71.7x	48.3x	35x
EV / FCF	277x	104x	120x	52.3x	98x	113x	61.4x	41.8x
FCF Yield	0.36%	0.96%	0.83%	1.91%	1.02%	0.89%	1.63%	2.39%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	2.24	3.24	0.74	-0.46	0.86	-0.2989	1.445	2.311
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	670.5	801.5	638.8	634.4	738.3	848.8	1,070	1,242
EBITDA ¹	230.5	246.9	128	117.3	140.3	177.1	247.4	320.7
EBIT ¹	215.2	232.2	94.29	82.08	101.8	137.1	199.2	267.5
Net income ¹	128.3	186	41.58	-25.51	48.89	-19.07	89.14	144.7
Net Debt ¹	-237.8	-339.1	-681.9	-231.8	-23.81	-810.9	-1,022	-1,293
Reference price ²	264.84	169.31	179.80	143.94	163.86	166.52	166.52	166.52
Nbr of stocks (in thousands)	55,289	55,524	55,832	56,027	56,291	63,924	-	-
Announcement Date	17/02/22	22/02/23	21/02/24	20/02/25	24/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
REPLIGEN CORPORATION	-577.52x	12.04x	57.72x	-.--%	11.03B
ABBOTT LABORATORIES	36.16x	4.26x	16x	2.37%	189B
MEDTRONIC PLC	22x	3.73x	13.36x	2.79%	124B
STRYKER CORPORATION	27.49x	4.88x	16.75x	1.13%	121B
ESSILORLUXOTTICA	32.04x	3.08x	12.44x	2.22%	93.09B
CENCORA, INC.	18.56x	0.22x	13.81x	0.68%	66.77B
BECTON, DICKINSON AND COMPANY	43.73x	3.85x	13.12x	1.95%	58.43B
IDEXX LABORATORIES, INC.	46.72x	11.72x	32.84x	-.--%	55.35B
HOYA CORPORATION	28.58x	7.08x	17.95x	1.41%	49.49B
MEDLINE INC.	52.92x	1.5x	13.9x	-.--%	37.04B
Average	-26.93x	5.24x	20.79x	1.26%	81B
Weighted average by Cap.	23.92x	4.44x	16.66x	1.7%